Literature DB >> 26596926

Colorectal Neoplasia and Inflammatory Bowel Disease.

Jamie Cannon1.   

Abstract

Inflammatory bowel disease is associated with an increased risk of gastrointestinal neoplasia. Ulcerative colitis increases the risk of colorectal cancer, and patients with this condition should undergo routine colonoscopic surveillance to detect neoplasia. Crohn's disease increases the risk of malignancy in inflamed segments of bowel, which may include small bowel, colon, rectum, and anus.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Crohn's disease; Inflammatory bowel disease; Neoplasia; Ulcerative colitis

Mesh:

Year:  2015        PMID: 26596926     DOI: 10.1016/j.suc.2015.08.001

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  10 in total

1.  DNA methylation, colon cancer and Mediterranean diet: results from the EPIC-Italy cohort.

Authors:  Francesca Fasanelli; Maria Teresa Giraudo; Paolo Vineis; Valentina Fiano; Giovanni Fiorito; Chiara Grasso; Silvia Polidoro; Morena Trevisan; Sara Grioni; Vittorio Krogh; Amalia Mattiello; Salvatore Panico; Maria Concetta Giurdanella; Rosario Tumino; Laura De Marco; Fulvio Ricceri; Carlotta Sacerdote
Journal:  Epigenetics       Date:  2019-06-14       Impact factor: 4.528

2.  Extraction, Chemical Composition, and Protective Effect of Essential Oil from Chimonanthus nitens Oliv. Leaves on Dextran Sodium Sulfate-Induced Colitis in Mice.

Authors:  Jing He; Yang Zhang; Kehui Ouyang; Lingli Chen; Wenya Meng; Ying Zhang; Wenjun Wang
Journal:  Oxid Med Cell Longev       Date:  2022-07-06       Impact factor: 7.310

Review 3.  Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Emma Altobelli; Paolo Matteo Angeletti; Giovanni Latella
Journal:  J Cancer       Date:  2016-10-08       Impact factor: 4.207

4.  The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.

Authors:  Toshiharu Sakurai; Hiroaki Higashitsuji; Hiroshi Kashida; Tomohiro Watanabe; Yoriaki Komeda; Tomoyuki Nagai; Satoru Hagiwara; Masayuki Kitano; Naoshi Nishida; Takaya Abe; Hiroshi Kiyonari; Katsuhiko Itoh; Jun Fujita; Masatoshi Kudo
Journal:  Oncotarget       Date:  2017-04-11

Review 5.  Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?

Authors:  Simona Pompili; Roberta Sferra; Eugenio Gaudio; Angelo Viscido; Giuseppe Frieri; Antonella Vetuschi; Giovanni Latella
Journal:  Int J Mol Sci       Date:  2019-08-20       Impact factor: 5.923

6.  Association of Colonic Diverticula with Colorectal Adenomas and Cancer.

Authors:  Angelo Viscido; Fabiana Ciccone; Filippo Vernia; Dolores Gabrieli; Annalisa Capannolo; Gianpiero Stefanelli; Stefano Necozione; Giorgio Valerii; Hassan Ashktorab; Giovanni Latella
Journal:  Medicina (Kaunas)       Date:  2021-01-25       Impact factor: 2.430

7.  Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis.

Authors:  Jia-Ling Shi; Ye-Hong Lv; Jun Huang; Xue Huang; Ying Liu
Journal:  World J Clin Cases       Date:  2022-01-21       Impact factor: 1.337

Review 8.  Targeting Inflammation to Improve Tumor Drug Delivery.

Authors:  Vasiliki Gkretsi; Lefteris C Zacharia; Triantafyllos Stylianopoulos
Journal:  Trends Cancer       Date:  2017-08-23

9.  Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells.

Authors:  Weina Zhang; Lechuang Chen; Kai Ma; Yahui Zhao; Xianghe Liu; Yu Wang; Mei Liu; Shufang Liang; Hongxia Zhu; Ningzhi Xu
Journal:  Oncotarget       Date:  2016-11-15

Review 10.  Comorbidity management in spondyloarthritis.

Authors:  Clementina López-Medina; Anna Molto
Journal:  RMD Open       Date:  2020-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.